Event Overview - The 8th edition of "Italy on the Move" will be hosted by the Italian Trade Agency (ITA) and the Ministry of Foreign Affairs and International Cooperation during the 43rd annual J P Morgan Healthcare Conference 2025 [1] - The event aims to promote investment opportunities in Italy's €270 billion life sciences sector, including biotech, healthcare, medical devices, and pharmaceuticals [1] - It will take place at INNOVIT, San Francisco's Italian Innovation and Culture Hub, on January 15, 2025, starting at 5:00 PM [1] Key Speakers and Participants - Opening remarks will be delivered by the Ambassador of Italy to the U S, H E Mariangela Zappia, and the Consul General of Italy in San Francisco, Sergio Strozzi [2] - Mauro Battocchi, Director General for the Promotion of the Italy System, will provide an overview of the Italian life sciences ecosystem [3] - A panel discussion titled "Navigating Transatlantic Partnerships in Life Sciences" will be moderated by Audrey Greenberg, Founder of the Center for Breakthrough Medicines and CEO of AG Capital Advisors [3] - Five Italian startups—Aavantgarde, Butterfly Decisions, Cellply, Medlea, and Sibylla Biotech—will present pitch presentations [4] Italian Life Sciences Sector Highlights - The Italian life sciences sector has a turnover of €270 billion, equivalent to 11% of the country's GDP [3] - Italy ranks 1st among EU economies in pharma CDMO manufacturing value and 4th worldwide in patents productivity in Life Sciences [3] - Nearly 50 life science multinationals have established production and R&D bases in Italy [3] - Pharmaceuticals and medical devices are the third most significant Italian export globally, surpassing iconic "Made in Italy" goods like apparel and wines [3] Event Objectives and Opportunities - The event serves as a platform for U S healthcare companies and investors to meet Italian companies for partnerships or investments [3] - It highlights Italy's potential as a competitive hub for international scientists, researchers, companies, and investors in the life sciences sector [3] - The event will showcase innovative SMEs and startups, offering opportunities for collaboration and investment [3] About the Organizers - The Italian Trade Agency (ITA) is a government agency that promotes the globalization of Italian firms and facilitates economic and trade relations with foreign countries, focusing on SMEs and partnerships [5] - INNOVIT, the Italian Innovation and Culture Hub, is a strategic initiative by the Italian Government to connect Italian innovative companies and startups with Silicon Valley and U S ecosystems [6]

Newest Evie Ring feature is the first medical journal trained AI companion in a wearable PLEASANTON, Calif., Jan. 8, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced the latest enhancement to its Evie smart ring for women with the beta release of EvieAI, the first wearable-based virtual wellness assistant trained exclusively with data from medical journals. The new feature enables Evie users to answer health questions quickly, reliably and securely through the ring's companion app. Planned ...

After strategic reshaping of its leadership team and service offerings, the brand shows why "It's time to move up" to ERAMADISON, N.J., Dec. 13, 2024 /PRNewswire/ -- ERA Real Estate, a global franchising leader within the Anywhere Real Estate Inc. (NYSE: HOUS) portfolio of brands, has launched a new marketing campaign, "It's time to move up," to reinforce the ERA® brand's promise to both agents and consumers.The campaign leveraged key findings from agents and consumer research and builds on the ERA® brand's ...

Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunitiesPLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring.  The clearance enables Movano Health to pursue multi-billion dollar business opportunities for health monitoring solutions needed for applications such as clinical trials, post-clinical trial ...

Movano Inc. (NASDAQ:MOVE) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants J. Cogan - CFO John Mastrototaro - CEO Tyla Bucher - Chief Marketing Officer Michael Soule - Chief Commercial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Operator Ladies and gentlemen, greetings, and welcome to the Movano Health Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to intr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware (Stateofincorporation) | --- | --- | |-------|-----------------------| | | ...

Exhibit 99 Movano Health Reports Q3 2024 Financial Results and Provides Business Update Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. – November 14, 2024 – Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to remain focus ...

Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to remain focused on three key business initiatives. Successful execution of the Evie Ring dir ...

New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc. (Nasdaq: MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5th and 6th hypoxia clinical trial that took place at the University of California, San Francisco. The updated device features an additional 12 mmWave antennas which together with Movano Health's custom IC delivers enhance ...

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., Nov. 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report third quarter 2024 financial and operating results on Thursday November 14, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. Attendees can access the live webcast here or on the inves ...